Sagimet Biosciences (SGMT) Free Cash Flow: 2023-2024
Historic Free Cash Flow for Sagimet Biosciences (SGMT) over the last 2 years, with Sep 2024 value amounting to -$19.6 million.
- Sagimet Biosciences' Free Cash Flow fell 404.49% to -$19.6 million in Q3 2024 from the same period last year, while for Sep 2024 it was -$38.5 million, marking a year-over-year change of. This contributed to the annual value of -$42.4 million for FY2024, which is 78.55% down from last year.
- Sagimet Biosciences' Free Cash Flow amounted to -$19.6 million in Q3 2024, which was down 247.34% from -$5.6 million recorded in Q2 2024.
- In the past 5 years, Sagimet Biosciences' Free Cash Flow registered a high of -$3.9 million during Q3 2023, and its lowest value of -$19.6 million during Q3 2024.
- Moreover, its 2-year median value for Free Cash Flow was -$6.2 million (2024), whereas its average is -$7.9 million.
- Examining YoY changes over the last 5 years, Sagimet Biosciences' Free Cash Flow showed a top increase of 12.37% in 2024 and a maximum decrease of 404.49% in 2024.
- Over the past 2 years, Sagimet Biosciences' Free Cash Flow (Quarterly) stood at -$7.1 million in 2023, then plummeted by 404.49% to -$19.6 million in 2024.
- Its last three reported values are -$19.6 million in Q3 2024, -$5.6 million for Q2 2024, and -$6.2 million during Q1 2024.